Liraglutide
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Novo Nordisk · Phase 3 · Completed · Enrollment 16
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Post LSG with Liraglutude | n/r | n/r | n/r | n/r |
| Post LSG without Liraglutide | n/r | n/r | n/r | n/r |
Not shown
- Post LSG with Liraglutude: endpoint not reported
- Post LSG without Liraglutide: endpoint not reported